Answers are grounded in this paper and cite their sources.
Figure S1. Brain 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) of patient 1. Table S1. Clinical features and laboratory findings of the patients. Table S2. In silico pathogenicity predictions of the AARS2 gene mutations. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: